Management of actinic cheilitis using diclofenac 3% gel: A report of six cases

British Journal of Dermatology

Volumn 156, Issue SUPPL. 3, 2007, Pages 43-46

  Ulrich, C ^a   Forschner, T ^a   Ulrich, M ^a   Stockfleth, E ^a   Sterry, W ^a   Termeer, C ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Actinic cheilitis; COX 2 inhibitor; Diclofenac 3 gel; Field management; Squamous cell carcinoma

Indexed keywords

DICLOFENAC;

ADULT; AGED; ARTICLE; CHEILITIS; CLINICAL ARTICLE; DRUG EFFICACY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SKIN BIOPSY; SKIN SWELLING; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEILITIS; DICLOFENAC; FEMALE; GELS; HUMANS; KERATOSIS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34247352114     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07863.x     Document Type: Article

References (34)

1. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathological characteristics in 65 cases. Oral Diseases 2004 10 : 212 16.
2. Baker SR. Current management of cancer of the lip. Oncology 1990 4 : 107 20.
3. Dufresne RG Jr., Curlin MU. Actinic cheilitis. A treatment review. Dermatol Surg 1997 23 : 15 21.
4. Wright K, Dufresne R. Actinic cheilitis. Dermatol Surg 1998 24 : 490 1.
5. Smith KJ, Germain M, Yeager J et al. Topical 5% imiquimod for the therapy of actinic cheilitis. J Am Acad Dermatol 2002 47 : 497 501.
6. Chakrabarty AK, Mraz S, Geisse JK et al. Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis. J Am Acad Dermatol 2005 52 : 35 7.
7. Smith SR, Morhenn VB, Piacquadio DJ. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol 2006 5 : 156 9.
8. Dawe SA, Salisbury JR, Higgins E. Two cases of Bowen's disease successfully treated topically with 3% diclofenac in 2.5% hyaluronan gel. Clin Exp Dermatol 2005 30 : 712 3.
9. Pirard D, Vereecken P, Melot C et al. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res 2005 297 : 185 9.
10. Meric JB, Rottey S, Olaussen K et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol 2006 59 : 51 64.
11. Mizutani Y, Nakanishi H, li YN et al. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522. J Urol 2004 172 : 1474 9.
12. Tanaka T, Delong PA, Amin K et al. Treatment of lung cancer using clinically relevant oral doses of the cyclooxygenase-2 inhibitor rofecoxib: potential value as adjuvant therapy after surgery. Ann Surg 2005 24 : 168 78.
13. Dannenberg AJ, Altorki NK, Boyle JO et al. Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract. Ann N Y Acad Sci 2001 952 : 109 15.
14. Gallo O, Franchi A, Magnelli L et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia 2001 3 : 53 61.
15. Kyzas PA, Stefanou D, Agnantis NJ. Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip. Oral Oncol 2004 40 : 941 7.
16. Pentland AP, Schoggins JW, Scott GA et al. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999 20 : 1939 44.
17. Chan G, Boyle JO, Yang EK et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999 59 : 991 4.
18. Vogt T, McClelland M, Jung B et al. Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II. Melanoma Res 2001 11 : 587 99.
19. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992 6 : 2397.
20. Termeer CC, Hennies J, Voith U et al. Oligosaccharides of hyaluronan are potent activators of dentric cells. J Immunol 2000 165 : 1863 70.
21. Termeer C, Benedix F, Sleeman J et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002 195 : 99 111.
22. Taylor KR, Trowbridge JM, Rudisill JA et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004 279 : 17079 84.
23. Jiang D, Liang J, Fan J et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005 11 : 1173 9.
24. Scheibner KA, Lutz MA, Boodoo S et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006 177 : 1272 81.
25. Asgari M, White E, Chren MM. Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg 2004 30 : 1335 42.
26. Sober AJ, Burstein JM. Precursors to skin cancer. Cancer 1995 75 (Suppl. 2 645 50.
27. Satorres Nieto M, Gargallo Albiol J, Gay Escoda C. Surgical management of actinic cheilitis. Med Oral 2001 6 : 205 17.
28. Sarachev EL, Ananostev NH. Surgical treatment of squamous cell carcinoma of the lower lip. Folia Med 2001 43 : 145 9.
29. Terezhalmy GT, Naylor GD. Actinic cheilitis. J Indiana Dent Assoc 1993 72 : 12 5.
30. Laws RA, Wilde JL, Grabski WJ. Comparison of electrodessication with CO2 laser for the treatment of actinic cheilitis. Dermatol Surg 2000 26 : 349 53.
31. Zelickson BD, Roenigk RK. Actinic cheilitis. Treatment with the carbon dioxide laser. Cancer 1990 65 : 1307 11.
32. Hauschild A, Lischner S, Lange-Asschenfeldt B et al. Treatment of actinic cheilitis using photodynamic therapy with methyl aminolevulinate: report of three cases. Dermatol Surg 2005 31 : 1344 7.
33. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol 2004 3 : 548 51.
34. Epstein E. Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil. Arch Dermatol 1977 113 : 906 8.